Staying ahead in biotech requires fast access to clear, reliable, and actionable information
The Harmony Biotech Resource Hub brings together valuable content - blogs, case studies, and videos - so leaders can quickly find answers, explore best practices, and learn proven approaches used across the life sciences industry.
Whether you're planning your next development milestone, evaluating partnerships, or preparing to scale, these resources provide the strategic context and operational guidance needed to make smarter decisions.
Biotech insights & expert analysis
Our blog delivers concise, evidence-based insights on the topics shaping today's biotech environment. Each article breaks down complex challenges in areas like R&D strategy, regulatory navigation, operational scale-up, and commercialization planning. The goal: provide biotech leaders with practical, actionable guidance they can apply immediately.
What Are the Best Practices for Implementing a Quality Management System in the Pharmaceutical Industry? Key Components and Compliance Strategies Explained
Implementing a Quality Management System (QMS) in the pharmaceutical industry is a critical step to ensure product safety, regulatory compliance, and patient trust. This article offers a high-level overview of the best practices for setting up and managing a QMS tailored specifically for pharmaceutical organizations. We will cover why a QMS matters, how to build…
Beyond Compliance: How Regulatory Consultants Add Strategic Value to Pharma and Biotech Companies
Pharma and biotech companies operate in an environment filled with complex regulations designed to ensure patient safety and product efficacy. But regulatory compliance is only one part of the story. In today’s fast-paced, innovation-driven landscape, regulatory consultants bring far more than just compliance expertise. They add strategic value that accelerates development, reduces risks, and helps…
Top Regulatory Requirements To Be Aware Of For Biotech Product Approval in 2026
The biotech industry is advancing faster than ever. New therapies and technologies hold promise to transform healthcare. But to reach patients, these innovations must clear complex regulatory hurdles. For companies developing biotech products in the U.S., understanding the key regulatory steps and legal requirements is essential, especially as these rules evolve. As we enter 2026,…
Biotech case studies: Real strategies, real results
Explore how biotech organizations have worked with Harmony Biotech to overcome operational challenges, accelerate timelines, and prepare for key inflection points. These case studies highlight proven frameworks, collaboration models, and measurable outcomes that support faster development and more effective decision-making.
Harmony Biotech Consulting
Featured case study: Drug development project
A commercial-stage biopharma company needed to scale its lyophilization process to meet EMA/FDA Requirements without major capital investment. Harmony redesigned upstream equipment and single-use technologies, developed and defended a robust validation strategy, and enabled a 10x scale-up using existing infrastructure. The solution avoided $10M in costs, prevented an 18-month delay, reduced regulatory risk, and ensured supply chain continuity.
Cell Therapy Project
Entry into Phase 1 With New Technology
The Challenge:
A cell therapy company is looking to make the jump into first-in-human trials from R&D studies. They have no previous experience with filing and IND.
Why Harmony?
Harmony was chosen because of their track record of working with small companies in emerging technological areas such as cell therapy and gene therapy and their long record managing successful regulatory submissions.
The Solution:
Harmony staff rapidly came up to speed with the technology and conducted a gap assessment for the company to determine what was needed to achieve compliance for P1 standards for a new cell therapy product. A game plan for each area (non-clinical, clinical, CMC, regulatory) was created with consensus with company staff, and converted into a simple table of contents. Harmony collated input from company staff into an IND while providing strategic guidance. Questions and responses from FDA were handled efficiently during the review period. The result was a successful approval of the IND and a rapid start for the P1 trial.
Small Molecule Oncology Project
New Operational Systems for GMP Compliance
The Challenge:
A company needed to create a GMP-compliant manufacturing system for its new small molecule product.
Why Harmony?
Harmony was chosen because of our depth and breadth of expertise in GMP operations. We were chosen because we offer a cost-effective, development-phase appropriate "Goldilocks" approach - do not do too much or too little - do the right amount of GMP compliance for the phase of development.
The Solution:
Harmony wrote an initial suite of 50 SOPs and batch records, along with an overarching Quality Manual. The company was audited and found to be compliant with GMP for clinical trial manufacturing.
Biotech Product - Aseptic Filling Project
Validation of A New Commerical Plant
The Challenge:
A company needed to perform validation of a new pilot-plant / early commercial manufacturing facility for an aseptically filled biotech product.
Why Harmony?
Harmony was chosen because of its documentation creation and technical writing skills, and the ability to rapidly create documents that are "fit-for-purpose" and useful for end-users while still being GMP compliant.
The Solution:
Harmony developed Validation Master Plans (VMPs) for equipment, computers, utilities, cleaning/environmental monitoring , and processes in accordance with FDA guidelines. In addition, Harmony wrote the critical process SOPs and validation protocols and coordinated with the architect and engineering firms. The facility was operational on time and on budget.
Monoclonal Antibody Project
Technology Transfer
The Challenge:
A company needed to transfer manufacturing of a radiolabeled monoclonal antibody product to a different facility.
Why Harmony?
Harmony was chosen because of our knowledge and extensive experience with antibodies and radionuclides.
The Solution:
Harmony sourced and audited prospective vendors. Within 6 months, the transfer was completed and submitted to FDA, saving the company $3 Million per year in manufacturing costs.
Biotech FAQ videos: Fast answers to common leadership questions
Our FAQ videos offer quick, high-value explanations to the questions biotech leaders ask most. Each short video provides clear, practical guidance on topics such as resource planning, partnership strategy, operational excellence, and growth readiness. Ideal for teams needing reliable answers - fast.
